Upstream Bio, Inc. (UPB)
Nasdaq · Pharmaceutical Preparations · Inc. DE
What they're doing
Not enough recent activity to summarise.
Signals, last 12 months
- Material 8-K filingFiled 8-K disclosing material agreement
Insider transactions
| Date | Insider | Role | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-09-16 | Houghton Adam | officer | S | 700 | 5.49 | $3,843 |
| 2026-09-16 | Sutherland Everett Rand | director | S | 2,095 | 5.49 | $11,502 |
| 2026-09-16 | Deykin Aaron | officer | S | 895 | 5.49 | $4,914 |
| 2026-09-16 | Ambrose Allison | officer | S | 485 | 5.49 | $2,663 |
| 2026-09-16 | GRAY MICHAEL | officer | S | 853 | 5.49 | $4,683 |
| 2026-06-16 | GRAY MICHAEL | officer | S | 853 | 6.1 | $5,203 |
| 2026-06-16 | Sutherland Everett Rand | director | S | 2,095 | 6.1 | $12,780 |
| 2026-06-16 | Houghton Adam | officer | S | 700 | 6.1 | $4,270 |
| 2026-06-16 | Deykin Aaron | officer | S | 895 | 6.1 | $5,460 |
| 2026-06-16 | Ambrose Allison | officer | S | 477 | 6.1 | $2,910 |
| 2026-06-16 | GRAY MICHAEL | officer | S | 853 | 6.1 | $5,203 |
| 2026-06-16 | Sutherland Everett Rand | director | S | 2,095 | 6.1 | $12,780 |
| 2026-06-16 | Houghton Adam | officer | S | 700 | 6.1 | $4,270 |
| 2026-06-16 | Deykin Aaron | officer | S | 895 | 6.1 | $5,460 |
| 2026-06-16 | Ambrose Allison | officer | S | 477 | 6.1 | $2,910 |
| 2026-03-16 | GRAY MICHAEL | officer | S | 852 | 9.29 | $7,915 |
| 2026-03-16 | Deykin Aaron | officer | S | 894 | 9.29 | $8,305 |
| 2026-03-16 | Sutherland Everett Rand | director | S | 2,093 | 9.29 | $19,444 |
| 2026-03-16 | Ambrose Allison | officer | S | 475 | 9.29 | $4,413 |
| 2026-03-16 | Houghton Adam | officer | S | 699 | 9.29 | $6,494 |
| 2026-03-16 | GRAY MICHAEL | officer | S | 852 | 9.29 | $7,915 |
| 2026-03-16 | Deykin Aaron | officer | S | 894 | 9.29 | $8,305 |
| 2026-03-16 | Sutherland Everett Rand | director | S | 2,093 | 9.29 | $19,444 |
| 2026-03-16 | Ambrose Allison | officer | S | 475 | 9.29 | $4,413 |
| 2026-03-16 | Houghton Adam | officer | S | 699 | 9.29 | $6,494 |
| 2026-01-02 | GRAY MICHAEL | officer | A | 30,500 | 0 | $0 |
| 2026-01-02 | Deykin Aaron | officer | A | 32,000 | 0 | $0 |
| 2026-01-02 | Ambrose Allison | officer | A | 17,000 | 0 | $0 |
| 2026-01-02 | Houghton Adam | officer | A | 25,000 | 0 | $0 |
| 2026-01-02 | Sutherland Everett Rand | director | A | 75,000 | 0 | $0 |
| 2026-01-02 | GRAY MICHAEL | officer | A | 30,500 | 0 | $0 |
| 2026-01-02 | Deykin Aaron | officer | A | 32,000 | 0 | $0 |
| 2026-01-02 | Ambrose Allison | officer | A | 17,000 | 0 | $0 |
| 2026-01-02 | Houghton Adam | officer | A | 25,000 | 0 | $0 |
| 2026-01-02 | Sutherland Everett Rand | director | A | 75,000 | 0 | $0 |
| 2024-10-15 | Chimovits Erez | director | C | 721,956 | — | — |
| 2024-10-15 | Chimovits Erez | director | P | 165,000 | 17 | $2,805,000 |
| 2024-10-15 | Chimovits Erez | director | C | 2,887,833 | — | — |
| 2024-10-15 | Chimovits Erez | director | P | 660,000 | 17 | $11,220,000 |
| 2024-10-15 | ORBIMED ADVISORS LLC | director | C | 2,887,833 | — | — |
| 2024-10-15 | ORBIMED ADVISORS LLC | director | P | 165,000 | 17 | $2,805,000 |
| 2024-10-15 | ORBIMED ADVISORS LLC | director | C | 721,956 | — | — |
| 2024-10-15 | ORBIMED ADVISORS LLC | director | P | 660,000 | 17 | $11,220,000 |
| 2024-10-15 | Access Industries Holdings LLC | ten percent owner | P | 1,175,000 | 17 | $19,975,000 |
| 2024-10-15 | Access Industries Holdings LLC | ten percent owner | C | 3,147,000 | — | — |
| 2024-10-15 | Access Industries Holdings LLC | ten percent owner | C | 1,172,410 | — | — |
| 2024-10-15 | Wellington Biomedical Innovation Master Investors (Cayman) II L.P. | ten percent owner | C | 894,733 | — | — |
| 2024-10-15 | Chimovits Erez | director | C | 721,956 | — | — |
| 2024-10-15 | Chimovits Erez | director | P | 165,000 | 17 | $2,805,000 |
| 2024-10-15 | Chimovits Erez | director | C | 2,887,833 | — | — |
Federal contracts
No federal contract actions on record for this recipient mapping.
Lobbying
No federal lobbying filings on record for this client mapping.
Public attention
No Wikipedia pageview data linked to this company.